Abrdn Healthcare Investors
HQHFinancial ServicesNASDAQAsset Management · Last scanned Oct 24, 2026
Scan Results
Daily timeframeAbrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. With a market capitalization of $1.16B, it sits in small-cap territory. The fund invests in public equity markets across the globe.
Market Cap
$1.16B
Beta
0.75
P/E (TTM)
4.53
P/E (Fwd)
—
EPS (TTM)
$4.47
EPS (Fwd)
—
ROE
24.2%
ROA
-0.4%
Cash
—
Total Debt
$0
Free CF
—
52W Change
6.7%
Annual Financials
Cash vs Debt
Where HQH stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, HQH finished 3.15% below its 150-day moving average ($20.03) and 0.21% below its 200-day moving average ($19.44). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HQH overbought or oversold?
At the October 20, 2026 close, HQH's RSI(14) was 32.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Abrdn Healthcare Investors carries $0 in total debt, a figure that investors should evaluate relative to the company's earnings power. ROE of 24.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from -$192.3M (2022) to $99.8M (2025), reflecting a 152% increase over the period.
Investors considering Abrdn Healthcare Investors should weigh the typical risks associated with HQH's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing HQH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.